Related references
Note: Only part of the references are listed.Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom
Lucia Cea Soriano et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Risk of progression in MGUS
S. Vincent Rajkumar
LANCET HAEMATOLOGY (2015)
Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study
Su-Hsin Chang et al.
LANCET HAEMATOLOGY (2015)
Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
Sevim Dalva-Aydemir et al.
CLINICAL CANCER RESEARCH (2015)
Global gene expression profiling in mouse plasma cell tumor precursor and bystander cells reveals potential intervention targets for plasma cell neoplasia
Jason LeGrand et al.
BLOOD (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
A monoclonal gammopathy precedes multiple myeloma in most patients
Brendan M. Weiss et al.
BLOOD (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
Cancer incidence in The Health Improvement Network
Kevin Haynes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Prevalence of monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States
LM Brown et al.
CANCER CAUSES & CONTROL (2001)
Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway
M Ferlin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
